Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NL-OMON22506Phase 4Active, not recruiting
Phase 4, randomised trial in postoperative pain comparing Bupivacaine + morphine with Bupivacaine + sufentanil (2 arms). Primary endpoint: Pain scores during first 72 hours after surgery. Started Mar 2010; status: active, not recruiting.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NL-OMON22506.